News

Filter

Current filters:

None

176 to 185 of 97856 results

No new bidders emerge for Dendreon, so Valeant gets Provenge

No new bidders emerge for Dendreon, so Valeant gets Provenge

11-02-2015

US biotech firm Dendreon revealed yesterday that the bid deadline provided by the Court-approved bidding…

BiotechnologyDendreonMergers & AcquisitionsOncologyProvengeValeant Pharmaceuticals International

US FDA fails to reveal concerns over clinical trial falsification

US FDA fails to reveal concerns over clinical trial falsification

11-02-2015

Some 22 clinical trials over 15 years have been affected by falsification, according to figures from…

Clinical researchPharmaceuticalPharmaceutical sciencesPharmacologyUSA

EMA explains its redaction rules, responding to Ombudsman questions

EMA explains its redaction rules, responding to Ombudsman questions

11-02-2015

The European Medicines Agency has published a detailed response to the European Ombudsman’s questions…

AbbVieEuropeHumiraPharmaceuticalRegulation

Seattle Genetics posts losses but beats analyst forecasts

Seattle Genetics posts losses but beats analyst forecasts

11-02-2015

Bothell, Washington, USA-headquartered oncology specialist Seattle Genetics managed to beat analyst estimates…

AdcetrisBiotechnologyFinancialOncologySeattle GeneticsUSA

Top-line Ph III results of Takeda’s oral ixazomib met primary endpoint

Top-line Ph III results of Takeda’s oral ixazomib met primary endpoint

10-02-2015

Japan’s largest drugmaker Takeda Pharmaceutical announced that the randomized, double-blind, placebo-controlled…

ixazomibOncologyPharmaceuticalResearchTakeda Pharmaceutical

Pfenex soars on Lucentis biosimilar deal with Hospira

Pfenex soars on Lucentis biosimilar deal with Hospira

10-02-2015

Shares of US clinical-stage biotech firm Pfenex leapt 28% to $8.85 in morning trading, after the company…

BiosimilarsBiotechnologyGenentechGlobalHospiraLicensingLucentisNovartisOphthalmicsPF582PfenexResearchRoche

Regeneron sees strong Eylea sales; financials beat expectations

Regeneron sees strong Eylea sales; financials beat expectations

10-02-2015

US biotech firm Regeneron Pharmaceuticals today announced financial results for the fourth quarter and…

BayerBiotechnologyEyleaFinancialOphthalmicsRegeneron PharmaceuticalsSanofi

Zubsolv market share boosts Orexo valuation, according to Edison research

Zubsolv market share boosts Orexo valuation, according to Edison research

10-02-2015

Swedish drug developer Orexo has laid the foundations to accelerate growth of its Zubsolv (buprenorphine…

FinancialMarkets & MarketingNeurologicalOrexoPharmaceuticalSwedenUSAZubsolv

GlaxoSmithKline encounters initial resistance following directional shift, says analyst

GlaxoSmithKline encounters initial resistance following directional shift, says analyst

10-02-2015

Following a less than flattering financial performance in 2014, UK pharma major GlaxoSmithKline is realigning…

FinancialGlaxoSmithKlineOncologyPharmaceuticalRespiratory and Pulmonary

176 to 185 of 97856 results

COMPANY SPOTLIGHT

Menarini

Back to top